Results 211 to 220 of about 457,035 (358)

Non-invasive estimation of pericardial effusion volume by three-dimensional speckle-tracking echocardiography (From the MAGYAR-Path Study)

Türk Kardiyoloji Derneği Arşivi, 2015
Attila Nemes, Péter Domsik, Anita Kalapos, Tamás Forster   +3 more
doaj   +1 more source

Hydralazine-Associated Pericardial Effusion Causing Cardiac Tamponade Without Hypotension. [PDF]

JACC Case Rep
Akele O, Bihag Z, Raj T, Satija V, Kaul A, Radford M, Lee J.   +6 more
europepmc   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Case Report: Cardiac angiosarcoma with rib pain as the first symptom. [PDF]

Front Oncol
Cai M, Chen X, Li J, Liu R, Zhou C.
europepmc   +1 more source

A Complicated Course of Pulmonary Tuberculosis With Cavitary Findings and Pleural Effusion. [PDF]

Cureus
Krakowski MW, Brito Vera ME, López-Royo Díaz de la Peña J, Perchetti GA, Gifford R, Lazarescu R.   +5 more
europepmc   +1 more source

Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.

Journal of the American Medical Association (JAMA), 2012
H. Davies, Eleanor K. Mishra, B. Kahan, J. Wrightson, A. Stanton, A. Guhan, C. Davies, J. Grayez, R. Harrison, A. Prasad, N. Crosthwaite, Y. C. G. Lee, R. Davies, Robert F. Miller, N. Rahman   +14 more
semanticscholar   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Biologic Rescue With Tocilizumab: A Case of Refractory Chronic Pericardial Effusion in Systemic Sclerosis. [PDF]

JACC Case Rep
Delgadillo R, Roufeh E, Lavelle B, Nguyen K, de la Rosa A.   +4 more
europepmc   +1 more source

Mast cells mediate malignant pleural effusion formation.

Journal of Clinical Investigation, 2015
A. Giannou, A. Marazioti, M. Spella, N. Kanellakis, Hara Apostolopoulou, I. Psallidas, Z. Prijovich, M. Vreka, D. Zazara, I. Lilis, Vassilios Papaleonidopoulos, Chrysoula A. Kairi, A. Patmanidi, I. Giopanou, N. Spiropoulou, V. Harokopos, V. Aidinis, D. Spyratos, S. Teliousi, H. Papadaki, S. Taraviras, L. Snyder, O. Eickelberg, D. Kardamakis, Y. Iwakura, T. Feyerabend, H. Rodewald, I. Kalomenidis, T. Blackwell, T. Agalioti, G. Stathopoulos   +30 more
semanticscholar   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source